Sargent Investment Group LLC Has $398,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sargent Investment Group LLC lowered its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.9% during the fourth quarter, HoldingsChannel reports. The firm owned 4,470 shares of the exchange traded fund’s stock after selling 180 shares during the quarter. Sargent Investment Group LLC’s holdings in SPDR S&P Biotech ETF were worth $398,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of XBI. Avior Wealth Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after buying an additional 307 shares in the last quarter. Tidemark LLC grew its holdings in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. bought a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000. ORG Wealth Partners LLC bought a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $44,000. Finally, Howe & Rusling Inc. bought a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $49,000.

SPDR S&P Biotech ETF Stock Up 2.3 %

XBI stock opened at $94.70 on Thursday. The business has a 50 day moving average price of $92.88 and a two-hundred day moving average price of $96.57. The company has a market cap of $7.22 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.